Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
3 Hot Reads From TheStreet's Top Premium Columnists
By Tedd Cohen
Apr 11, 2018 3:00 PM EDT
JIM CRAMER
We Got Too Negative: Cramer's 'Mad Money' Recap
By Scott Rutt
Apr 10, 2018 6:29 AM EDT
MARKETS
Markets Keep Eye on China Presidential Speech; Biotechs Bounce -- ICYMI
By Michael Brown
Apr 9, 2018 8:00 PM EDT
MARKETS
Dow Rises Sharply on Softer U.S. Approach in China Trade War; Tech Soars
By Joseph Woelfel
Apr 9, 2018 4:09 PM EDT
VIDEO
Video: Jim Cramer Reacts to Novartis' Acquisition of AveXis
By Jim Cramer
Apr 9, 2018 12:13 PM EDT
MARKETS
Stock Futures Are on a Mild Tear Monday After Brutal Friday Selloff
By Lisa Botter
Apr 9, 2018 8:06 AM EDT
MARKETS
Deutsche Bank, Novartis, AveXis, Facebook, Patrick Reed - 5 Things You Must Know
By Joseph Woelfel
Apr 9, 2018 7:44 AM EDT
VIDEO
5 Thing You Must Know Before Monday's Opening Bell
By Tracy Byrnes
Apr 9, 2018 7:21 AM EDT
MERGERS AND ACQUISITIONS
Novartis Agrees to Buy AveXis in $8.7 Billion Deal
By Lisa Botter
Apr 9, 2018 3:19 AM EDT
OPINION
Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?
By Brian Sozzi
Mar 20, 2018 4:43 PM EDT
STOCKS
15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies
By Kinsey Grant
Mar 20, 2018 2:58 PM EDT
STOCKS
3 Stocks You Probably Never Heard Of Could Catch Fire Soon
By Roberto Pedone
Jun 22, 2017 11:03 AM EDT
HEALTH
Biotech Movers: AveXis, Clovis, Epizyme
By Armie Margaret Lee
Jun 20, 2017 9:33 AM EDT
STOCKS
High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying Kids
By Adam Feuerstein
Apr 26, 2017 7:42 AM EDT
HEALTH
AveXis, Esperion and Amgen Among Biotech Movers
By Armie Margaret Lee
Mar 17, 2017 11:03 AM EDT
STOCKS
5 Earnings Short-Squeeze Plays
By Roberto Pedone
Mar 14, 2017 2:05 PM EDT
STOCKS
3 stocks setting up for major breakouts
By Roberto Pedone
Feb 17, 2017 2:26 PM EST
STOCKS
Hurry! These 5 stocks are about to break out explosively
By Roberto Pedone
Jan 13, 2017 2:35 PM EST
STOCKS
Ionis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen Option
By Adam Feuerstein
Aug 1, 2016 12:51 PM EDT
STOCKS
Analysts' Actions -- Domino's, McDonald's, Priceline, Tesla and More
By TheStreet Staff
Jun 22, 2016 8:07 AM EDT
OPINION
What you need to know about biotech ipos this year
By Siddhi Bajaj
Jun 3, 2016 12:55 PM EDT
